|
Mechanism | Cell lines/animal models | In vitro/in vivo | Assay/treatment | Results | References |
|
Cell viability inhibition | 1 MCF-7 cell 2 Hs578T cells | In vitro | An MTT assay | (i) At 12.5 μM, NOB decreased the cell viability to 85.3 ± 4.5% At 25 μM, NOB decreased the cell viability to 79.3 ± 7.0% At 50 μM, NOB decreased the cell viability to 71.2 ± 5.0% At 100 μM, NOB decreased the cell viability to 60.3 ± 6.0% At 200 μM, NOB decreased the cell viability to 54.4 ± 4.5% (ii) At 100 μM, NOB showed greater toxicity toward the more invasive Hs578Ts(i)8 variant cell line, decreasing the cell viability to 51.6% after 72 h | [88] [89] |
|
Cell growth inhibition | Hs578T cells | In vitro | Cell counting | After 24 h, limited effects were observed After 48 h, NOB reduced the number of cells by 40% After 72 h, NOB reduced the number of cells by 50% | [89] |
|
Cell cycle arrest | Hs578T cells | In vitro | Western blot assay | Chk2 phosphorylation at T68 decreased after 10 min in the presence of NOB | [89] |
|
Cell cycle arrest | MCF-7 cells | In vitro | Flow cytometry assay | At 100 μM of NOB, a G1 block occurred in MCF-7 cells that was accompanied | [90] |
|
Proliferation inhibition | MCF-7, T47D, MDA-MB-231c | In vitro | An MTT assay | NOB had a strong inhibitory effect on the proliferation of MDA-MB-231 cells and a weak inhibitory effect on the proliferation of HUVEC cells | [91] |
|
Proliferation inhibition | MDA-MB-435, MCF-7 | In vitro | Cell counting | Inhibition rates of NOB on treated cells ranged from 60 to 95%, beginning at 12 h and lasting up to 4 days, in all cell lines | [92] |
|
Proliferation inhibition | Breast cancer model (i) Adult female Sprague Dawley rats with body weights (BWs) of 180–220 g (6-7 weeks old) | In vivo | DMBA (control rats) NOB (experimental rats) | (i) Compared with normal rats, the expression of proliferation-related proteins was increased in DMBA-treated rats (ii) NOB-treated rats showed downregulation of cell proliferation protein expression (iii) No significant changes were observed in the normal control group and rats treated with NOB alone | [93] |
|
Apoptosis promotion | MCF-7 cells | In vitro | Flow cytometry assay | At 50 μM, NOB induced cell apoptosis at the rates of 8.62 ± 3.5% At 100 μM, NOB induced cell apoptosis at the rates of 11.2 ± 2.0% At 200 μM, NOB induced cell apoptosis at the rates of 17.1 ± 3.7% The apoptosis rate of untreated cells was 5.4 ± 0.97% | [88] |
|
Migration inhibition | 1 MCF-7 cell 2 Hs578T cells | In vitro | Wound healing assay | (i) At 200 μM of NOB, the inhibition rates of the migration were 38.2 ± 3.2% after 24 h At 200 μM of NOB, the inhibition rates of the migration were 44.8 ± 2.5% after 48 h (ii) At 100 μM of NOB, the migration was reduced by 40% in the Hs578Ts(i)8 cell | [88] [89] |
|
Migration inhibition | MCF-7 cells | In vitro | Western blot assay | The expression levels of MMP-2 and MMP-9 were decreased in MCF-7 cell lines | [88] |
|
Expression of protein connected with BC | MCF-7 cells | In vitro | Western blot and quantified protein levels of total p65 and nuclear p65 p38 and p-p38 Total Nrf2 and nuclear Nrf2 | (i) At 50, 100, and 200 μM, NOB downregulated the translocation of p65 in the MCF-7 cells (ii) NOB had no significant effect on p65 protein expression at this concentration (iii) At 100 and 200 μM of NOB, the level of p-p38 was significantly increased At 50 μM, NOB had no significant effect on p38 phosphorylation At 100 and 200 μM, NOB significantly affected the expression of p38 (iv) At 100 and 200 μM, NOB significantly reduced the levels of Nrf2 At 50 μM, NOB had no obvious effect | [88] |
|
Angiogenesis inhibition | MCF-7, T47D cells | In vitro | Angiogenesis assay Western blot assay RT-PCR analysis Electrophoretic mobility shift assay (EMSA) | At 200 μM, NOB significantly inhibited tube formation in the extracellular matrix At 200 μM of NOB, the inhibition of angiogenesis occurred in HUVEC cells (i) NOB downregulated the expression of phosphorylated EGFR (ii) NOB reduced the expression levels of phosphorylated Src, FAK, STAT3, and PXN (iii) After NOB treatment for 24 h, angiogenic factors were inhibited (iv) NOB downregulated the DNA/STAT3 complex in MCF-7 and T47D cells | [91] |
|